Cited by 358Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders

Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.

Asia Pacific Cohort Studies Collaboration·2004·Circulation

Abstract

BACKGROUND: The importance of serum triglyceride levels as a risk factor for cardiovascular diseases is uncertain. METHODS AND RESULTS: We performed an individual participant data meta-analysis of prospective studies conducted in the Asia-Pacific region. Cox models were applied to the combined data from 26 studies to estimate the overall and region-, sex-, and age-specific hazard ratios for major cardiovascular diseases by fifths of triglyceride values. During 796,671 person-years of follow-up among 96,224 individuals, 670 and 667 deaths as a result of coronary heart disease (CHD) and stroke, respectively, were recorded. After adjustment for major cardiovascular risk factors, participants grouped in the highest fifth of triglyceride levels had a 70% (95% CI, 47 to 96) greater risk of CHD death, an 80% (95% CI, 49 to 119) higher risk of fatal or nonfatal CHD, and a 50% (95% CI, 29% to 76%) increased risk of fatal or nonfatal stroke compared with those belonging to the lowest fifth. The association between triglycerides and CHD death was similar across subgroups defined by ethnicity, age, and sex. CONCLUSIONS: Serum triglycerides are an important and independent predictor of CHD and stroke risk in the Asia-Pacific region. These results may have clinical implications for cardiovascular risk prediction and the use of lipid-lowering therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1161/01.cir.0000145615.33955.83

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several meta-analyses from studies performed in the general population have shown a modest but independent effect of triglycerides on CVD.

    “Several meta-analyses from studies performed in the general population have shown a modest but independent effect of triglycerides on CVD.”

    From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [134]

    The Discussion (page unavailable) calls this work a meta-analysis of Asia-Pacific cohorts and reports an association between triglycerides and cardiovascular risk independent of other measured risk factors. It also mentions one previous meta-analysis with a similar finding. The paper therefore supports the independent association, but not the broader claim that several meta-analyses of general-population studies have shown it. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • A meta-analysis based on Asian and Pacific populations calculated a relative risk for coronary heart disease, adjusted for several established risk factors, of 1.80 (95% CI, 1.49-2.19), comparing subjects in the top with those in the bottom quintile of triglyceride levels.

    “This latter meta-analysis calculated a relative risk for coronary heart disease, adjusted for several established risk factors, of 1.80 (95% CI, 1.49 -2.19), comparing subjects in the top with those in the bottom quintile of triglyceride levels.”

    From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [134]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • High TG is associated with CAD risk in Europe, the US, Asia, Oceania, and Japan.

    “There have been numerous reports on the association between a high TG level and the risk for CAD not just in Europe and the US86), but also in Asia, Oceania87) and even in Japan46, 78, 88–91).”
  • The association between TG and CAD was observed even with normal HDL-C.

    “Despite a normal range of HDL-C, the association between TG and CAD was still observed in several of these studies86–89).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Bainton D, Miller NE, Bolton CH, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. Br Heart J. 1992;68:60 -66.

Cited by

Sorted by citations

Authors
Asia Pacific Cohort Studies Collaboration
Affiliations
The University of Sydney (AU)
Corresponding author
Asia Pacific Cohort Studies Collaboration
Venue
Circulation
Published
2004-10-26
Volume
110
Issue
17
Pages
2678-2686
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2117541022
Cited by
358
References
51
Citations by year
2026: 3 · 2025: 9 · 2024: 13 · 2023: 20 · 2022: 13 · 2021: 15 · 2020: 13 · 2019: 17 · 2018: 15 · 2017: 12 · 2016: 22 · 2015: 19 · 2014: 21 · 2013: 21 · 2012: 24
FWCI
9.79
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Funders
  • Pfizer
  • National Institutes of Health
  • Medical Research Council
  • National Health and Medical Research Council
  • Health Research Council of New Zealand
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
serum triglycerides, cardiovascular risk, coronary artery disease, stroke, cardiovascular mortality, lipid-lowering therapy, cardiovascular risk prediction, Asia-Pacific population
MeSH terms
Aged, Asia, Australia, Coronary Disease, Female, Humans, Male, Middle Aged, New Zealand, Risk Factors, Triglycerides, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review